When obstetricians kept coming to Robert Norman, an IVF specialist, telling him he had to do something, he knew they were right. ''We lost another set of twins,'' they would tell him. Or they would relate harrowing stories of babies born too early, and of women with preeclampsia and other complications from carrying twins or triplets-all a result of implanting two or more embryos during assisted reproduction. ''This is unacceptable,'' the doctors would tell him.
Norman, then head of the reproductive medicine unit at the University of Adelaide, in Australia, was in a position to address this problem. Beginning in the late 1990s, Norman and his colleagues initiated a research program that would ultimately lead to a major reduction in multiple birth rates at the university's clinic and set the stage for nationwide change. The rate of multiple pregnancies from assisted reproduction has shifted countrywide from 21.4 percent in 2001 to below 7 percent in 2011, according to the most recent data available [1] .
''The whole of fertility practice changed,'' said Norman, in a talk co-sponsored by the American Society for Reproductive Medicine at the annual meeting of the Society for the Study of Reproduction this July in Grand Rapids, Michigan. In his talk and in a follow-up interview with Biology of Reproduction, Norman told the story of how this change was fostered by a research group, centered at the University of Adelaide that would in 2008 become the Robinson Research Institute. His story highlights the success of a close collaboration between bench scientists and clinical researchers-a formula for translational medicine that the institute, which Norman led from 2008 to 2013, is now applying to other issues in reproductive sciences, such as the effect of being overweight on fertility and offspring health.
Too Many Twins
When Norman and his colleagues first began to think about how to approach the problem of multiple pregnancies, they were facing several obstacles. One was the then-entrenched view that multiple-embryo transfer resulted in higher success rates than single-embryo transfer-women were more likely to become pregnant, the thinking went. But what if that view was wrong?
Some clinicians took a more conservative approach, transferring a single embryo, and if that one didn't take, transferring another. There was very little evidence assessing the outcome of either strategy-so Norman and his colleagues designed a clinical trial involving close to a dozen clinics across the country. The trial was designed to compare single vs. multiple embryo transfer, and assess outcomes such as pregnancy success rates.
To do the trial correctly, the researchers had to find a way to maximize the success of single-embryo transfer, and standardize its implementation. Norman and his colleagues tapped into basic research from Australia and New Zealand-including that of Jeremy Thompson and Michelle Lane, both now at the Robinson Research Institute. They had been perfecting culture medium for assisted reproduction in various animal models. These advances led to the use of a standardized, optimized culture medium for single-embryo transfer-superior to the largely random assortment of culture mediums used throughout the 1990s. The researchers also began to transfer single embryos that had been frozen, a technique that emerged from animal research some of it at the University of Adelaide, the advantage being that embryos can be transferred when the uterus is most receptive.
The clinical sites also instituted a program Norman called ''Total Quality Management'' in which every clinical and laboratory aspect of assisted reproduction is tightly controlled, right down to the quality of the petri dishes. As a result of such changes, the women in the trial undergoing single-embryo transfer had an optimized chance of success.
We Don't Want It
What happened next surprised Norman and his colleagues. ''Nobody wanted to have double-embryo transfer because they were so appalled by the potential risk,'' he said. As part of the clinical trial, the researchers educated subjects about the dangers of multiple pregnancy. About 11 percent of twins, for instance, are born very early, before 32 weeks, compared to 2 percent of singletons [2] . As a result of patient education, even before the trial was completed, it had begun to influence clinical practice-women country-wide were beginning to opt for single-embryo transfer.
There was another crucial factor in the patients' decisions, said Norman. The Australian government provides financial support for assisted reproduction, roughly equalizing the costs to the patient of repeated single-embryo transfer vs. a multipleembryo transfer. By supporting this approach, the Australian health service ultimately saves money, given the high cost of caring for twins, with their elevated rates of prematurity and later-life complications such as cerebral palsy.
The results of the Australian study were promising but, because of problems with recruitment, not published until 2010 as part of a meta-analysis [3] . That study, like many that had been emerging in the previous several years, showed that the pregnancy rates were roughly equivalent between multipleembryo transfer and single-embryo transfer, with two attempts at implantation.
But by 2010, much had already changed in Australia. The Fertility Society of Australia made restrictions on singleembryo transfer a precondition for being accredited in 2005, and now aims for each clinic to have a multiple pregnancy rate below 10 percent. What's more, the Australian government agreed only to fund drugs for assisted reproduction at accredited clinics-all of which accelerated change in Australia throughout the last decade. In 2011, about 74 percent of transfers in Australia were of a single embryo [1] .
''The main effect of the clinical trial was that it changed people's attitude, in practices and in patients,'' said Norman; ''as a result, there was confidence in the accreditation authorities to encourage single-embryo transfer.'' Behind the policy shifts, says Norman, was a research group that fostered close collaboration between animal scientists, bench researchers, and clinical researchers, ''all of that integrated to create high-quality human embryology and clinical practice.''
Taking It to the Street
The changes in assisted reproduction in Australia have been mirrored in several other countries, such as Sweden, that now have high rates of single-embryo transfer. But in other countries such as the United States, the practice has not been widely adopted. In 2011, only 12 percent of women under 35 practiced elective single-embryo transfer in the US, transferring only one embryo even if others are available [4] . That year, the rate of twin births from assisted reproduction in the US was 27 percent-about 58 percent of these twins were born preterm [4] .
In an interview, Norman pointed out that high costs for fertility treatment in the United States inhibit change-patients generally must pay for each ''cycle'' of implantation, and coverage by insurers is meager. This barrier is also highlighted by other experts, such as in a recent analysis [5] by the Yale Fertility Center and the Hastings Center, a bioethics research institute.
Buoyed by the Australian success at single-embryo transfer, the Robinson Research Institute is now applying its multidisciplinary, translational approach to peri-conception medicine. For instance, basic scientists there are studying how food intake and weight of parents affect embryonic and fetal development in animals, and clinical researchers are asking how best to counsel patients about their risks and translating that message to patients-such as through a popular website the institute helped develop, ''Your Fertility'' [6] . Now, fewer obstetricians are approaching Norman. ''A small change can make a big difference,'' said Norman at the meeting, ''Reproductive biology can inform clinical practice and policy to change society.''
